Stephen Hoge, President at Moderna, Inc. (MRNA), sold 160,009 shares at $48.84 ($7.8M) on 2026-02-23, disclosed to the SEC on 2026-02-25.
Seasonal sale ($7.8M) by President — this insider has traded MRNA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| MRNA | SELL | 2026-07-16 | $3.6M | — | Filing → |
| MRNA | SELL | 2026-06-17 | $2.7M | — | Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |